HMGB2, a member of the high-mobility group box (HMG-box) family, has emerged as a critical regulator of tumor progression through its involvement in cell cycle regulation, metabolic reprogramming, and immune evasion mechanisms. The gene discussed is HMGB2; the disease is neoplasm.